Inorganic Nanobiomaterials Boost Tumor Immunotherapy: Strategies and Applications
Accounts of Chemical Research · 2025
DOI: 10.1021/acs.accounts.4c00843 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Accounts of Chemical Research, 2025. Verfasst von Qi Meng und 3 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, Ch…. Hauptthemen laut MEDLINE: Immunotherapy, Neoplasms, Nanostructures, Inorganic Chemicals. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 84 Literaturangaben. Gefördert von: Jilin Provincial Scientific and Technological Development Program, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, China.
- School of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei, 230026, China.
ORCID-Profile: Qi Meng, Binbin Ding, Ping'an Ma, Jun Lin
Förderung
- Jilin Provincial Scientific and Technological Development Program
- National Natural Science Foundation of China
Zitieren
APA
Meng, Q., Ding, B., Ma, P., & Lin, J. (2025). Inorganic Nanobiomaterials Boost Tumor Immunotherapy: Strategies and Applications. Accounts of Chemical Research. https://doi.org/10.1021/acs.accounts.4c00843
Vancouver
Meng Q, Ding B, Ma P, Lin J. Inorganic Nanobiomaterials Boost Tumor Immunotherapy: Strategies and Applications. Accounts of Chemical Research. 2025. doi:10.1021/acs.accounts.4c00843
BibTeX
@article{Meng2025,
author = {Meng, Qi and Ding, Binbin and Ma, Ping'an and Lin, Jun},
title = {Inorganic Nanobiomaterials Boost Tumor Immunotherapy: Strategies and Applications},
journal = {Accounts of Chemical Research},
year = {2025},
doi = {10.1021/acs.accounts.4c00843}
}
EUVIMED